Genetics 100 for Cardiologists: Basics of Genome-Wide Association Studies

Canadian Journal of Cardiology

Volumn 29, Issue 1, 2013, Pages 10-17

  Dubé, Joseph B ^a   Hegele, Robert A ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOLOGIST; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHROMOSOME 9P; CORONARY ARTERY DISEASE; DNA MICROARRAY; DNA SEQUENCE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN GENOME; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHERN BLOTTING;

CARDIOLOGY; CORONARY ARTERY DISEASE; DATABASES, GENETIC; DNA; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84871414655     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.10.011     Document Type: Article

References (46)

1. D'Agostino R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
2. Genest J., McPherson R., Frohlich J., et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 2009, 25:567-579.
3. Teslovich T.M., Musunuru K., Smith A.V., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
4. Imamura M., Maeda S. Genetics of type 2 diabetes: the GWAS era and future perspectives. Endocr J 2011, 58:723-739.
5. Kathiresan S., Srivastava D. Genetics of human cardiovascular disease. Cell 2012, 148:1242-1257.
6. Altshuler D., Daly M.J., Lander E.S. Genetic mapping in human disease. Science 2008, 322:881-888.
7. Lanktree M.B., Dichgans M., Hegele R.A. Advances in genomic analysis of stroke: what have we learned and where are we headed?. Stroke 2010, 41:825-832.
8. Gianfagna F., Cugino D., Santimone I., Iacoviello L. From candidate gene to genome-wide association studies in cardiovascular disease. Thromb Res 2012, 129:320-324.
9. Pollex R.L., Hegele R.A. Copy number variation in the human genome and its implications for cardiovascular disease. Circulation 2007, 115:3130-3138.
10. Hindorff L.A., Sethupathy P., Junkins H.A., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009, 106:9362-9367.
11. Dickson S.P., Wang K., Krantz I., Hakonarson H., Goldstein D.B. Rare variants create synthetic genome-wide associations. PLoS Biol 2010, 8:e1000294.
12. Orozco G., Barrett J.C., Zeggini E. Synthetic associations in the context of genome-wide association scan signals. Hum Mol Genet 2010, 19:R137-R144.
13. Bernstein B.E., Birney E., Dunham I., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
14. Botstein D., White R.L., Skolnick M., Davis R.W. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 1980, 32:314-331.
15. Hegele R.A. SNP judgments and freedom of association. Arterioscler Thromb Vasc Biol 2002, 22:1058-1061.
16. The International HapMap Project. Nature 2003, 426:789-796. International HapMap Consortium.
17. Lander E.S. The new genomics: global views of biology. Science 1996, 274:536-539.
18. Reich D.E., Lander E.S. On the allelic spectrum of human disease. Trends Genet 2001, 17:502-510.
19. Pritchard J.K., Cox N.J. The allelic architecture of human disease genes: common disease-common variant... or not?. Hum Mol Genet 2002, 11:2417-2423.
20. Lanktree M.B., Guo Y., Murtaza M., et al. Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height. Am J Hum Genet 2011, 88:6-18.
21. Chasman D.I., Pare G., Zee R.Y., et al. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ Cardiovasc Genet 2008, 1:21-30.
22. Schunkert H., Konig I.R., Kathiresan S., et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011, 43:333-338.
23. Voight B.F., Scott L.J., Steinthorsdottir V., et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010, 42:579-589.
24. Nolte I.M., Wallace C., Newhouse S.J., et al. Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies. PLoS One 2009, 4:e6138.
25. Ehret G.B., Munroe P.B., Rice K.M., et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011, 478:103-109.
26. Speliotes E.K., Willer C.J., Berndt S.I., et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010, 42:937-948.
27. Attia J., Ioannidis J.P., Thakkinstian A., et al. How to use an article about genetic association: A: Background concepts. JAMA 2009, 301:74-81.
28. Attia J., Ioannidis J.P., Thakkinstian A., et al. How to use an article about genetic association: B: Are the results of the study valid?. JAMA 2009, 301:191-197.
29. Davies R.W., Wells G.A., Stewart A.F., et al. A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ Cardiovasc Genet 2012, 5:217-225.
30. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316:1488-1491.
31. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316:1491-1493.
32. Visel A., Zhu Y., May D., et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010, 464:409-412.
33. Harismendy O., Notani D., Song X., et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 2011, 470:264-268.
34. Paynter N.P., Chasman D.I., Buring J.E., et al. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med 2009, 150:65-72.
35. Paynter N.P., Chasman D.I., Pare G., et al. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA 2010, 303:631-637.
36. Ripatti S., Tikkanen E., Orho-Melander M., et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 2010, 376:1393-1400.
37. Thanassoulis G., Peloso G.M., Pencina M.J., et al. A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ Cardiovasc Genet 2012, 5:113-121.
38. Talmud P.J., Cooper J.A., Palmen J., et al. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem 2008, 54:467-474.
39. Brautbar A., Pompeii L.A., Dehghan A., et al. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis 2012, 223:421-426.
40. Lluis-Ganella C., Subirana I., Lucas G., et al. Assessment of the value of a genetic risk score in improving the estimation of coronary risk. Atherosclerosis 2012, 222:456-463.
41. Voight B.F., Kang H.M., Ding J., et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 2012, 8:e1002793.
42. Cortes A., Brown M.A. Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011, 13:101.
43. Maouche S., Schunkert H. Strategies beyond genome-wide association studies for atherosclerosis. Arterioscler Thromb Vasc Biol 2012, 32:170-181.
44. Holdt L.M., Teupser D. Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler Thromb Vasc Biol 2012, 32:196-206.
45. Dube J.B., Johansen C.T., Hegele R.A. Sortilin: an unusual suspect in cholesterol metabolism: from GWAS identification to in vivo biochemical analyses, sortilin has been identified as a novel mediator of human lipoprotein metabolism. Bioessays 2011, 33:430-437.
46. McPherson R. From Genome-wide association studies to functional genomics: new insights into cardiovascular disease. Can J Cardiol 2013, 29:23-29.